This compound contains the 4-pyridylanilinothiazole moiety that has shown to selectively target von Hippel-Lindau deficient renal carcinoma cells (RCC). A derivative of isonicotinic acid (I821760), used in the biological study of differentiation induced by nicotinic acid, nicotinamide and isonicotinic acid in human leukemia cell lines.